| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | apyrase activity | 1.00e-05 | 3 | 37 | 2 | GO:0004050 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 1.48e-05 | 26 | 37 | 3 | GO:0004435 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 2.07e-05 | 29 | 37 | 3 | GO:0004629 | |
| GeneOntologyMolecularFunction | UDP phosphatase activity | 1.19e-04 | 9 | 37 | 2 | GO:0045134 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.18e-04 | 12 | 37 | 2 | GO:0004382 | |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 6.22e-04 | 20 | 37 | 2 | GO:0017110 | |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | 6.89e-04 | 386 | 37 | 5 | GO:0042578 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 7.66e-04 | 97 | 37 | 3 | GO:0008081 | |
| GeneOntologyMolecularFunction | ubiquitin binding | 1.02e-03 | 107 | 37 | 3 | GO:0043130 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.10e-03 | 110 | 37 | 3 | GO:0008238 | |
| GeneOntologyMolecularFunction | phospholipase activity | 1.22e-03 | 114 | 37 | 3 | GO:0004620 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein binding | 1.70e-03 | 128 | 37 | 3 | GO:0032182 | |
| GeneOntologyMolecularFunction | lipase activity | 2.11e-03 | 138 | 37 | 3 | GO:0016298 | |
| Domain | GDA1_CD39 | 1.06e-04 | 8 | 37 | 2 | PF01150 | |
| Domain | GDA1_CD39_NTPASE | 1.06e-04 | 8 | 37 | 2 | PS01238 | |
| Domain | GDA1_CD39_NTPase | 1.06e-04 | 8 | 37 | 2 | IPR000407 | |
| Domain | PIPLC_Y_DOMAIN | 3.95e-04 | 15 | 37 | 2 | PS50008 | |
| Domain | PI-PLC_fam | 3.95e-04 | 15 | 37 | 2 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.95e-04 | 15 | 37 | 2 | IPR015359 | |
| Domain | PI-PLC-Y | 3.95e-04 | 15 | 37 | 2 | PF00387 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.95e-04 | 15 | 37 | 2 | IPR001711 | |
| Domain | EF-hand_like | 3.95e-04 | 15 | 37 | 2 | PF09279 | |
| Domain | PLCYc | 3.95e-04 | 15 | 37 | 2 | SM00149 | |
| Domain | PI-PLC-X | 5.73e-04 | 18 | 37 | 2 | PF00388 | |
| Domain | PLCXc | 5.73e-04 | 18 | 37 | 2 | SM00148 | |
| Domain | PIPLC_X_DOMAIN | 6.39e-04 | 19 | 37 | 2 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 6.39e-04 | 19 | 37 | 2 | IPR000909 | |
| Domain | - | 1.11e-03 | 25 | 37 | 2 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 1.11e-03 | 25 | 37 | 2 | IPR017946 | |
| Domain | CH | 7.34e-03 | 65 | 37 | 2 | SM00033 | |
| Domain | CH | 8.47e-03 | 70 | 37 | 2 | PF00307 | |
| Domain | - | 8.71e-03 | 71 | 37 | 2 | 1.10.418.10 | |
| Domain | CH | 9.19e-03 | 73 | 37 | 2 | PS50021 | |
| Domain | CH-domain | 9.68e-03 | 75 | 37 | 2 | IPR001715 | |
| Domain | PH_dom-like | 9.73e-03 | 426 | 37 | 4 | IPR011993 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.22e-04 | 8 | 30 | 2 | M27737 | |
| Pathway | REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS | 1.22e-04 | 8 | 30 | 2 | MM15486 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 1.24e-04 | 46 | 30 | 3 | M48317 | |
| Pathway | WP_GPR40_PATHWAY | 4.52e-04 | 15 | 30 | 2 | M39526 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.70e-04 | 72 | 30 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.89e-04 | 73 | 30 | 3 | MM15906 | |
| Pubmed | Expression of phospholipase C isozymes in human breast cancer and their clinical significance. | 3.48e-06 | 3 | 38 | 2 | 28112359 | |
| Pubmed | Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. | 6.96e-06 | 4 | 38 | 2 | 18404504 | |
| Pubmed | Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. | 6.96e-06 | 4 | 38 | 2 | 17727821 | |
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 7589147 | ||
| Pubmed | 4.16e-05 | 9 | 38 | 2 | 10501179 | ||
| Pubmed | 7.62e-05 | 12 | 38 | 2 | 21705333 | ||
| Pubmed | 1.05e-04 | 14 | 38 | 2 | 36573432 | ||
| Pubmed | 1.76e-04 | 18 | 38 | 2 | 1979339 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 1.76e-04 | 18 | 38 | 2 | 12119179 | |
| Pubmed | 2.03e-04 | 104 | 38 | 3 | 9205841 | ||
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | 2.36e-04 | 516 | 38 | 5 | 36610398 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.84e-04 | 1201 | 38 | 7 | 35696571 | |
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 9730685 | ||
| Pubmed | 2.90e-04 | 23 | 38 | 2 | 9278385 | ||
| Pubmed | 3.16e-04 | 24 | 38 | 2 | 10843712 | ||
| Pubmed | 4.01e-04 | 27 | 38 | 2 | 20336759 | ||
| Pubmed | 6.38e-04 | 34 | 38 | 2 | 10613844 | ||
| Pubmed | Signaling pathways triggered by HIV-1 Tat in human monocytes to induce TNF-alpha. | 7.97e-04 | 38 | 38 | 2 | 12482669 | |
| Pubmed | 7.97e-04 | 38 | 38 | 2 | 23273568 | ||
| Pubmed | 1.06e-03 | 1084 | 38 | 6 | 11544199 | ||
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 1.07e-03 | 44 | 38 | 2 | 27534441 | |
| Pubmed | 1.09e-03 | 417 | 38 | 4 | 19199708 | ||
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 3.35e-04 | 19 | 26 | 2 | 832 | |
| GeneFamily | Phospholipases | 1.65e-03 | 42 | 26 | 2 | 467 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.17e-03 | 181 | 26 | 3 | 694 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.84e-02 | 394 | 26 | 3 | 471 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-02 | 160 | 26 | 2 | 555 | |
| Coexpression | GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN | 1.01e-05 | 200 | 38 | 5 | M6789 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 2.15e-05 | 97 | 36 | 4 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 3.17e-05 | 107 | 36 | 4 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.69e-05 | 225 | 36 | 5 | gudmap_developingGonad_e14.5_ ovary_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 6.20e-05 | 413 | 36 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 1.82e-04 | 65 | 36 | 3 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.02e-04 | 323 | 36 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | 2.89e-04 | 76 | 36 | 3 | GSM538248_100 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-SMG_basal_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.29e-07 | 158 | 38 | 5 | adad97e6cf479d42791c5ba9cbc5f15f469322bf | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.39e-07 | 171 | 38 | 5 | 26b34dc069cc15b75a0c13cb8c5d81e074788160 | |
| ToppCell | Entopeduncular|World / BrainAtlas - Mouse McCarroll V32 | 1.03e-05 | 160 | 38 | 4 | 833763c8608de4ee6003b8fb682aa9c83d7dea9b | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; PC3; HT_HG-U133A | 1.33e-05 | 195 | 36 | 5 | 4664_DN | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.47e-05 | 199 | 36 | 5 | 3668_DN | |
| Drug | ADP beta S | 1.58e-05 | 96 | 36 | 4 | CID005310996 | |
| Drug | 2-chloroadenosine | 2.00e-05 | 102 | 36 | 4 | CID000008974 | |
| Drug | hexachlorocyclopentadiene | 2.42e-05 | 5 | 36 | 2 | CID000006478 | |
| Drug | riboxin | 2.50e-05 | 36 | 36 | 3 | CID000006831 | |
| Disease | HWESASXX measurement | 3.38e-05 | 7 | 38 | 2 | EFO_0021147 | |
| Disease | Autism Spectrum Disorders | 1.81e-04 | 85 | 38 | 3 | C1510586 | |
| Disease | Movement Disorders | 6.41e-04 | 29 | 38 | 2 | C0026650 | |
| Disease | nephrolithiasis | 8.31e-04 | 33 | 38 | 2 | EFO_0004253 | |
| Disease | Inherited neuropathies | 1.22e-03 | 40 | 38 | 2 | C0598589 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YTHLRISYNVYLAVY | 411 | P41180 | |
| VDRYLSLYYALTYHS | 136 | P47775 | |
| IHEYISGYYRVSSYF | 456 | Q9UNQ0 | |
| ASYLHTFAYQNTIYL | 501 | P15144 | |
| KQIFHYSYTASYVIY | 146 | Q8N608 | |
| YSYTASYVIYNIHTR | 151 | Q8N608 | |
| SLYGYVYTLYTHSFQ | 246 | O75355 | |
| VYLLYKTSHYNILYA | 216 | Q96DC9 | |
| YTLLPYLYTLFYHAH | 666 | Q2M2H8 | |
| RLYGSDYSVYTHSYL | 231 | Q5MY95 | |
| LSLLEYVYINYLFYS | 341 | Q9UN88 | |
| IYYKTISYYNHIDSL | 331 | Q5W064 | |
| LTYVSQYYNYFHGRS | 96 | Q8IY33 | |
| YGSAIYTYLQSIHNY | 251 | Q8NGV0 | |
| HDYYTTEFLYNLYSS | 631 | P17858 | |
| NTHTYFYTSFAAYIF | 286 | Q8TCT9 | |
| TNYSYSYYEKLHTYF | 326 | P16144 | |
| HYKSLYRLAFLYTYS | 1526 | Q9Y6J0 | |
| RYYLSLLYCHLYSYN | 871 | Q9H799 | |
| SNFYFSYSYDLSHSL | 161 | Q92562 | |
| VIYYYAAAQTTHTTY | 1206 | Q9HC77 | |
| YCYTLEVSFYSYIIS | 396 | Q5VU57 | |
| YSLNVTYNYPVHYFD | 291 | Q9NV96 | |
| TSSAFLLFQLYYYKH | 16 | O75072 | |
| FYLSGTYYALYFLAT | 96 | Q96HE8 | |
| LPLSYYYIESSHNTY | 1396 | Q9P212 | |
| AYLLYSLHLNSCLYY | 796 | Q14028 | |
| SVLLYYTFHSQSLYY | 216 | Q5M7Z0 | |
| YTFHSQSLYYSLIFL | 221 | Q5M7Z0 | |
| YYLQNQHTYFSLTLL | 81 | Q5GH72 | |
| EKSIITYVATYYHYF | 266 | O15020 | |
| LNAAYSAYLQSYLSY | 566 | Q8IUC6 | |
| HQHYYYDTHTNTYYL | 196 | P55011 | |
| VYYGHTNYIYSISVF | 226 | Q9Y263 | |
| YYTHYSSAIIVASYL | 2631 | Q6ZS81 | |
| YPHYFVLTSSKIYYS | 506 | P19174 | |
| GQLYYHYYLRTSETS | 131 | Q8N9R8 | |
| SVYSYHSYYAQPSLT | 1256 | O43151 | |
| YLHNYSTNLAIISFY | 2166 | Q68DK2 | |
| STYSQLSPRHYYSGY | 741 | Q5R3F8 | |
| SEPYSIYTYRYFIHN | 236 | Q147X3 |